Schifanella, L., Binello, N., Vaccari, M., Gordon, S. N., Caccuri, F., Blackburn, M., … Franchini, G. (2014). Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251. In AIDS Research and Human Retroviruses (Vol. 30, pp. A20–A20). Mary Ann Liebert Inc. https://doi.org/10.1089/aid.2014.5024.abstract

Schifanella, Luca, Nicolo Binello, Monica Vaccari, Shari N. Gordon, Francesca Caccuri, Matthew Blackburn, Melvin Doster, et al. “Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251.” In AIDS Research and Human Retroviruses, 30:A20–A20. Mary Ann Liebert Inc, 2014. https://doi.org/10.1089/aid.2014.5024.abstract.

Schifanella L, Binello N, Vaccari M, Gordon SN, Caccuri F, Blackburn M, et al. Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251. In: AIDS Research and Human Retroviruses. Mary Ann Liebert Inc; 2014. p. A20–A20.

Schifanella, Luca, et al. “Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251.” AIDS Research and Human Retroviruses, vol. 30, no. S1, Mary Ann Liebert Inc, 2014, pp. A20–A20. Crossref, doi:10.1089/aid.2014.5024.abstract.

Schifanella L, Binello N, Vaccari M, Gordon SN, Caccuri F, Blackburn M, Doster M, Liynage N, Pegu P, Shen X, Tomaras GD, Venzon D, Stablien D, Barnett SW, Barouch D, Phogat S, Franchini G. Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251. AIDS Research and Human Retroviruses. Mary Ann Liebert Inc; 2014. p. A20–A20.